The History of Autologous Hematopoietic Cell Transplantation

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

Volumn , Issue , 2009, Pages 8-14

  Armitage, James O ^a  

^a NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Allogeneic bone marrow transplantation cure for autoimmune disease; Autologous bone marrow transplantation and autologous peripheral blood cell transplantation; Autologous hematopoietic cell transplantation; Autologous hematopoietic cell transplantation chronic myeloid with chronic lymphocytic leukemia; Clinical advances reflecting advances in basic science; High dose therapy and autologous HCT Hodgkin's disease; In vitro treatment of autologous hematopoietic blood or marrow collection

Indexed keywords

EID: 84890632225     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303537.ch2     Document Type: Chapter

References (121)

1. Frei E, 3rd, Canellos GP. Dose: A critical factor in cancer chemotherapy. Am J Med 1980; 69: 585-94.
2. Quine WE. The remedial application of bone marrow. JAMA 1896; 26: 1012-13.
3. Alpen EL, Baum SJ. Modification of X-radiation lethality by autologous marrow infusion in dogs. Blood 1958; 13: 1168-75.
4. Mannick JA, Lochte HL, Jr., Ashley CA, Thomas ED, Ferrebee JW. Autografts of bone marrow in dogs after lethal total-body radiation. Blood 1960; 15: 255-66.
5. Kurnick NB, Montano A, Gerdes JC, Feder BH. Preliminary observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. Ann Intern Med 1958; 49: 973-86.
6. Kurnick NB, Feder BH, Montano A, Gerdes JC, Nakamura R. Some observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. Ann Intern Med 1959; 51: 1204-19.
7. McFarland W, Granville NB, Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood 1959; 14: 503-21.
8. Clifford P, Clift RA, Duff JK. Nitrogen-mustard therapy combined with autologous marrow infusion. Lancet 1961; 1: 687-90.
9. Pegg DE, Humble JG, Newton KA. The clinical application of bone marrow grafting. Br J Cancer 1962; 16: 417-35.
10. Kurnick NB. Autologous and isologous bone marrow storage and infusion in the treatment of myelo-suppression. Transfusion 1962; 2: 178-87.
11. Appelbaum FR, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978; 52: 85-95.
12. Appelbaum FR, Deisseroth AB, Graw RG, Jr. et al. Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse. Cancer 1978; 41: 1059-63.
13. Cavins JA, Kasakura S, Thomas ED, Ferrebee JW. Recovery of lethally irradiated dogs following infusion of autologous marrow stored at low temperature in dimethylsulphoxide. Blood 1962; 20: 730-4.
14. Robinson WA, Hartmann DW, Mangalik A, Morton N, Joshi JH. Autologous nonfrozen bone marrow transplantation after intensive chemotherapy: A pilot study. Acta Haematol 1981; 66: 145-53.
15. Carella AM, Giordano D, Santini G et al. High dose BCNU followed by autologous bone marrow infusion in glioblastoma multiforme. Tumori 1981; 67: 473-5.
16. Carella AM, Santini G, Frassoni F et al. Autologous bone marrow transplantation without cryopreservation after megadoses of oncolytic chemotherapy. Pilot study in 18 cases. Haematologica 1983; 68: 620-37.
17. Carella AM, Santini G, Giordano D et al. Highdose chemotherapy and non-frozen autologous bone marrow transplantation in relapsed advanced lymphomas or those resistant to conventional chemotherapy. Cancer 1984; 54: 2836-9.
18. Carella AM, Santini G, Santoro A et al. Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease. Eur J Cancer Clin Oncol 1985; 21: 607-13.
19. Goodman JW, Hodgson GS. Evidence for stem cells in the peripheral blood of mice. Blood 1962; 19: 702-14.
20. Storb R, Graham TC, Epstein RB, Sale GE, Thomas ED. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 1977; 50: 537-42.
21. Appelbaum FR. Hemopoietic reconstitution following autologous bone marrow and peripheral blood mononuclear cell infusions. Exp Hematol 1979; 7 Suppl 5: 7-11.
22. Hershko C, Gale RP, Ho WG, Cline MJ. Cure of aplastic anaemia in paroxysmal nocturnal haemoglobinuria by marrow transfusion from identical twin: Failure of peripheral-leucocyte transfusion to correct marrow aplasia. Lancet 1979; 1: 945-7.
23. Abrams RA, Glaubiger D, Appelbaum FR, Deisseroth AB. Result of attempted hematopoietic reconstitution using isologous, peripheral blood mononuclear cells: A case report. Blood 1980; 56: 516-20.
24. Kessinger A, Armitage JO, Landmark JD, Weisenburger DD. Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 1986; 14: 192-6.
25. Cline MJ, Golde DW. Mobilization of hematopoietic stem cells (CFU-C) into the peripheral blood of man by endotoxin. Exp Hematol 1977; 5: 186-90.
26. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976; 47: 1031-9.
27. Abrams RA, McCormack K, Bowles C, Deisseroth AB. Cyclophosphamide treatment expands the circulating hematopoietic stem cell pool in dogs. J Clin Invest 1981; 67: 1392-9.
28. Gianni AM, Siena S, Bregni M et al. Granulocytemacrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580-5.
29. Duhrsen U, Villeval JL, Boyd J, Kannourakis G, Morstyn G, Metcalf D. Effects of recombinant human granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 1988; 72: 2074-81.
30. Socinski MA, Cannistra SA, Elias A, Antman KH, Schnipper L, Griffin JD. Granulocytemacrophage colony stimulating factor expands the circulating haemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194-8.
31. Sheridan WP, Begley CG, Juttner CA et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G- CSF) on platelet recovery after high-dose chemotherapy [see comments]. Lancet 1992; 339: 640-4.
32. Haas R, Ho AD, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocytemacrophage colony-stimulating factor. Exp Hematol 1990; 18: 94-8.
33. Kessinger A, Bishop MR, Jackson JD et al. Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. Exp Hematol 1995; 23: 609-12.
34. Bolwell BJ, Fishleder A, Andresen SW et al. GCSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: Parameters affecting bone marrow engraftment. Bone Marrow Transplant 1993; 12: 609-14.
35. Haas R, Mohle R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-94.
36. Kanteti R, Miller K, McCann J et al. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: A clinical and molecular analysis. Bone Marrow Transplant 1999; 24: 473-81.
37. Vose JM, Sharp G, Chan WC et al. Autologous transplantation for aggressive non-Hodgkin's lymphoma: Results of a randomized trial evaluating graft source and minimal residual disease. J Clin Oncol 2002; 20: 2344-52.
38. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following highdose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
39. Joshi SS, Kessinger A, Mann SL et al. Detection of malignant cells in histologically normal bone marrow using culture techniques. Bone Marrow Transplant 1987; 1: 303-10.
40. Johnson PW, Price CG, Smith T et al. Detection of cells bearing the t(14; 18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 1994; 12: 798-805.
41. Gribben JG, Freedman AS, Neuberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma [see comments]. N Engl J Med 1991; 325: 1525-33.
42. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 1992; 79: 1074-80.
43. Glorieux P, Bouffet E, Philip I et al. Metastatic interstitial pneumonitis after autologous bone marrow transplantation. A consequence of reinjection of malignant cells? Cancer 1986; 58: 2136-9.
44. Rossetti F, Deeg HJ, Hackman RC. Early pulmonary recurrence of non-Hodgkin's lymphoma after autologous marrow transplantation: Evidence for reinfusion of lymphoma cells? Bone Marrow Transplant 1995; 15: 429-32.
45. Schultz FW, Martens AC, Hagenbeek A. The contribution of residual leukemic cells in the graft to leukemia relapse after autologous bone marrow transplantation: mathematical considerations. Leukemia 1989; 3: 530-4.
46. Brenner MK, Rill DR, Moen RC et al. Genemarking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-6.
47. Nadler LM, Takvorian T, Botnick L et al. Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma. Lancet 1984; 2: 427-31.
48. De Fabritiis P, Bregni M, Lipton J et al. Elimination of clonogenic Burkitt's lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 1985; 65: 1064-70.
49. Hagenbeek A, Martens AC. Cryopreservation of autologous marrow grafts in acute leukemia: Survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells. Leukemia 1989; 3: 535-7.
50. Gorin NC, Lopez M, Laporte JP et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non- Hodgkin's lymphoma. Blood 1995; 85: 1647-54.
51. Berenson RJ, Bensinger WI, Hill RS et al. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-22.
52. Philip T, Biron P, Herve P et al. Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis. Eur J Cancer Clin Oncol 1983; 19: 1371-9.
53. Gorin NC, Najman A, Douay L et al. Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas. Eur J Cancer Clin Oncol 1984; 20: 217-25.
54. Appelbaum FR, Sullivan KM, Thomas ED et al. Experimental hematology today. New York: Springer-Verlag; 1985.
55. Verdonck LF, Dekker AW, van Kempen ML et al. Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non- Hodgkin's lymphoma of high-grade malignancy. Blood 1985; 65: 984-9.
56. Armitage JO, Jagannath S, Spitzer G et al. High dose therapy and autologous marrow transplantation as salvage treatment for patients with diffuse large cell lymphoma. Eur J Cancer Clin Oncol 1986; 22: 871-7.
57. Armitage JO, Gingrich RD, Klassen LW et al. Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation, and autologous marrow transplantation for refractory lymphoma. Cancer Treat Rep 1986; 70: 871-5.
58. Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non- Hodgkin's lymphoma. N Engl J Med 1987; 316: 1493-8.
59. Philip T, Chauvin F, Armitage J et al. Parma international protocol: Pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 1991; 77: 1587-92.
60. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy- sensitive non-Hodgkin's lymphoma [see comments]. N Engl J Med 1995; 333: 1540-5.
61. Liang R, Chen F, Lee CK et al. Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 1997; 19: 91-3.
62. Colombat P, Binet C, Linassier C et al. High dose chemotherapy with autologous marrow transplantation in follicular lymphomas. Leuk Lymphoma 1992; 7 Suppl: 3-6.
63. Rohatiner AZ, Johnson PW, Price CG et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 1994; 12: 1177-84.
64. Schouten HC, Bierman PJ, Vaughan WP et al. Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood 1989; 74: 2579-84.
65. Schouten HC, Qian W, Kvaloy S et al. High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: Results from the randomized European CUP trial. J Clin Oncol 2003; 21: 3918-27.
66. Milpied N, Ifrah N, Kuentz M et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989; 73: 82-7.
67. Santini G, Coser P, Chisesi T et al. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. A pilot study of the non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Bone Marrow Transplant 1989; 4: 399-404.
68. Sweetenham JW, Santini G, Qian W et al. High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/ maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group. J Clin Oncol 2001; 19: 2927-36.
69. Jagannath S, Dicke KA, Armitage JO et al. Highdose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's disease. Ann Intern Med 1986; 104: 163-8.
70. Philip T, Dumont J, Teillet F et al. High dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin's disease. Br J Cancer 1986; 53: 737-42.
71. Carella AM, Congiu AM, Gaozza E et al. High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: An Italian study group report. J Clin Oncol 1988; 6: 1411-6.
72. Phillips GL, Wolff SN, Herzig RH et al. Treatment of progressive Hodgkin's disease with intensive chemoradiotherapy and autologous bone marrow transplantation. Blood 1989; 73: 2086-92.
73. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: Results of a BNLI randomised trial. Lancet 1993; 341: 1051-4.
74. Schmitz N, Pfistner B, Sextro M et al. Aggressive conventional chemotherapy compared with highdose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: A randomised trial. Lancet 2002; 359: 2065-71.
75. McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; 2: 822-4.
76. Barlogie B, Alexanian R, Smallwood L et al. Prognostic factors with high-dose melphalan for refractory multiple myeloma. Blood 1988; 72: 2015-19.
77. Anderson KC, Andersen J, Soiffer R et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-76.
78. Reece DE, Barnett MJ, Connors JM et al. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide. Bone Marrow Transplant 1993; 11: 139-46.
79. Dimopoulos MA, Alexanian R, Przepiorka D et al. Thiotepa, busulfan, and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324-8.
80. Fermand JP, Chevret S, Ravaud P et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-9.
81. Jagannath S, Vesole DH, Glenn L, Crowley J, Barlogie B. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-72.
82. Schiller G, Vescio R, Freytes C et al. Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995; 86: 390-7.
83. Attal M, Harousseau JL, Stoppa AM et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91-7.
84. Gorin NC, Najman A, Duhamel G. Autologous bone-marrow transplantation in acute myelocytic leukaemia. Lancet 1977; 1: 1050.
85. Gorin NC, Douay L, Laporte JP et al. Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood 1986; 67: 1367-76.
86. Yeager AM, Kaizer H, Santos GW et al. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 1986; 315: 141-7.
87. Carella AM, Martinengo M, Santini G et al. Autologous bone marrow transplantation for acute leukemia in remission. The Genoa experience. Haematologica 1988; 73: 119-24.
88. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-23.
89. Kersey JH, Weisdorf D, Nesbit ME et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 1987; 317: 461-7.
90. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC. Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. N Engl J Med 1983; 308: 1493-8.
91. Finney R, McDonald GA, Baikie AG, Douglas AS. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia. Br J Haematol 1972; 23: 283-8.
92. Buckner CD, Stewart P, Clift RA et al. Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol 1978; 6: 96-109.
93. Brito-Babapulle F, Apperley JF, Rassool F, Guo AP, Dowding C, Goldman JM. Complete remission after autografting for chronic myeloid leukaemia. Leuk Res 1987; 11: 1115-17.
94. Rabinowe SN, Soiffer RJ, Gribben JG et al. Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1366-76.
95. Khouri IF, Keating MJ, Vriesendorp HM et al. Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results. J Clin Oncol 1994; 12: 748-58.
96. Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984; 2: 1281-8.
97. Tannir N, Spitzer G, Schell F, Legha S, Zander A, Blumenschein G. Phase II study of high-dose amsacrine (AMSA) and autologous bone marrow transplantation in patients with refractory metastatic breast cancer. Cancer Treat Rep 1983; 67: 599-600.
98. Antman KH. Dose-intensive therapy in breast cancer. In: Armitage JO, Antman KH, editors. High-dose cancer therapy -pharmacology, hematopoietins, stem cells. Baltimore, MD: Williams & Wilkins; 1992. pp. 701-718.
99. Rodenhuis S, Richel DJ, van der Wall E et al. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement. Lancet 1998; 352: 515-21.
100. Weiss RB, Gill GG, Hudis CA. An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol 2001; 19: 2771-7.
101. Weiss RB, Rifkin RM, Stewart FM et al. Highdose chemotherapy for high-risk primary breast cancer: An on-site review of the Bezwoda study. Lancet 2000; 355: 999-1003.
102. Phillips GL, Wolff SN, Fay JW et al. Intensive 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) monochemotherapy and autologous marrow transplantation for malignant glioma. J Clin Oncol 1986; 4: 639-45.
103. Knight WA, Goodman P, Taylor SA et al. Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group Study. Invest New Drugs 1990; 8: S87-S89.
104. Ariel IM, Pack GT. Treatment of disseminated melanoma with phenylalanine mustard (melphalan) and autogenous bone marrow transplants. Surgery 1962; 51: 582.
105. Thomas MR, Robinson WA, Glode LM et al. Treatment of advanced malignant melanoma with high-dose chemotherapy and autologous bone marrow transplantation. Preliminary results -phase I study. Am J Clin Oncol 1982; 5: 611-22.
106. Cornbleet MA, McElwain TJ, Kumar PJ et al. Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation. Br J Cancer 1983; 48: 329-34.
107. Pritchard J, McElwain TJ, Graham-Pole J. Highdose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 1982; 45: 86-94.
108. Mulder PO, Willemse PH, Aalders JG et al. Highdose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer. Eur J Cancer Clin Oncol 1989; 25: 645-9.
109. Farha P, Spitzer G, Valdivieso M et al. High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 1983; 52: 1351-5.
110. Souhami RL, Harper PG, Linch D et al. Highdose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 1982; 8: 31-4.
111. Glode LM, Robinson WA, Hartmann DW, Klein JJ, Thomas MR, Morton N. Autologous bone marrow transplantation in the therapy of small cell carcinoma of the lung. Cancer Res 1982; 42: 4270-5.
112. Smith IE, Evans BD, Harland SJ. High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer. Cancer Treat Rev 1983; 10 Suppl A: 79-81.
113. Nichols CR, Tricot G, Williams SD et al. Doseintensive chemotherapy in refractory germ cell cancer -a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 1989; 7: 932-9.
114. Einhorn LH, Williams SD, Chamness A, Brames MJ, Perkins SM, Abonour R. High-dose chemotherapy and stem-cell rescue for metastatic germcell tumors. N Engl J Med 2007; 357: 340-8.
115. Ikehara S, Good RA, Nakamura T et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A 1985; 82: 2483-7.
116. Marmont AM, Van Bekkum DW. Stem cell transplantation for severe autoimmune diseases: New proposals but still unanswered questions. Bone Marrow Transplant 1995; 16: 497-8.
117. Salzman P, Tami J, Jackson C et al. Clinical remission of myasthenia gravis after high dose chemotherapy and autologous transplantation with CD34+ stem cells [abstract]. Blood 1994; 84 Suppl 1: 206a.
118. Fastenrath S, Dreger P, Schmitz N. Autologous unpurged bone marrow transplantation in a patient with lymphoma and SLE: Short-term recurrence of antinuclear antibodies [abstract]. Arthritis Rheum 1005; 38: S303.
119. Joske DJ, Ma DT, Langlands DR, Owen ET. Autologous bone-marrow transplantation for rheumatoid arthritis. Lancet 1997; 350: 337-8.
120. Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: Sustained response in two of four patients. Arthritis Rheum 1999; 42: 2281-5.
121. Snowden JA, Biggs JC, Milliken ST, Fuller A, Brooks PM. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis. Arthritis Rheum 1999; 42: 2286-92.